Vaccine News and Research

Latest Vaccine News and Research

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Amorfix provides update on development of blood test for vCJD

Amorfix provides update on development of blood test for vCJD

Mucosis receives € 3M innovation credit line from Dutch Ministry for development of FluGEM influenza vaccine

Mucosis receives € 3M innovation credit line from Dutch Ministry for development of FluGEM influenza vaccine

RNAi therapy shuts down gene critical to RSV, prevents virus replication

RNAi therapy shuts down gene critical to RSV, prevents virus replication

Study demonstrates protection against Ebola infection in nonhuman primates using RNAi

Study demonstrates protection against Ebola infection in nonhuman primates using RNAi

Research roundup: Reform's impact on health spending; Cultural/Racial differences in medicine; Swine flu lessons

Research roundup: Reform's impact on health spending; Cultural/Racial differences in medicine; Swine flu lessons

VaxGen signs definitive agreement to acquire diaDexus in stock-for-stock merger

VaxGen signs definitive agreement to acquire diaDexus in stock-for-stock merger

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Previous recommendations on H1N1 pandemic influenza vaccine still stand: SAGE

Helicobacter pylori's helical shape helps it colonize the stomach

Helicobacter pylori's helical shape helps it colonize the stomach

Effective infant vaccina­tion against pneumonia needed in sub-Saharan Africa

Effective infant vaccina­tion against pneumonia needed in sub-Saharan Africa

Not all strains of influenza die off at the end of winter, reveals genetic analysis

Not all strains of influenza die off at the end of winter, reveals genetic analysis

Biomedical engineering professor receives Transition Career Development Award

Biomedical engineering professor receives Transition Career Development Award

Small molecule ramps up interferon production in host cells, launching potent immune response

Small molecule ramps up interferon production in host cells, launching potent immune response

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

Researchers study safety and immunogenicity of two H1N1 vaccines in UK children

The Wistar Institute Melanoma Research Center launched to develop new therapies for melanoma

The Wistar Institute Melanoma Research Center launched to develop new therapies for melanoma

ART associated with reduced risk of HIV transmission to sexual partners, study shows

ART associated with reduced risk of HIV transmission to sexual partners, study shows

ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine

ARCA receives approval to begin enrollment of first therapeutic trial with GeoVax vaccine

HZI researchers develop new method to produce insulin for treatment of diabetes

HZI researchers develop new method to produce insulin for treatment of diabetes

Modified measles virus may hold potential for treatment of medulloblastoma

Modified measles virus may hold potential for treatment of medulloblastoma

Space Shuttle Atlantis returns from International Space Station with tenth scientific payload for Astrogenetix

Space Shuttle Atlantis returns from International Space Station with tenth scientific payload for Astrogenetix

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.